EVMN
Evommune Inc

251
Mkt Cap
$792.04M
Volume
209,825.00
52W High
$33.20
52W Low
$13.89
PE Ratio
-9.87
EVMN Fundamentals
Price
$23.63
Prev Close
$21.99
Open
$23.00
50D MA
$22.36
Beta
1.84
Avg. Volume
1.29M
EPS (Annual)
-$2.18
P/B
3.37
Rev/Employee
$270,833.33
$392.55
Loading...
Loading...
News
all
press releases
Evommune (NYSE:EVMN) Stock Price Up 7.5% - Should You Buy?
Evommune (NYSE:EVMN) Trading Up 7.5% - Should You Buy...
MarketBeat·11h ago
News Placeholder
More News
News Placeholder
Evommune (NYSE:EVMN) Trading Down 6.7% - Here's What Happened
Evommune (NYSE:EVMN) Stock Price Down 6.7% - Here's Why...
MarketBeat·7d ago
News Placeholder
Evommune (NYSE:EVMN) Trading 6.9% Higher - Time to Buy?
Evommune (NYSE:EVMN) Trading Up 6.9% - Here's What Happened...
MarketBeat·10d ago
News Placeholder
Evommune (NYSE:EVMN) Issues Quarterly Earnings Results, Misses Expectations By $0.61 EPS
Evommune (NYSE:EVMN - Get Free Report) announced its quarterly earnings results on Thursday. The company reported ($1.43) earnings per share for the quarter, missing the consensus estimate of ($0.82...
MarketBeat·10d ago
News Placeholder
Evommune, Inc Loss At -$28.27 Mln In Q4
(RTTNews) - Evommune, Inc (EVMN) reported Loss for fourth quarter of -$28.27 million...
Nasdaq News: Markets·11d ago
News Placeholder
Evommune Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Highlights
Evommune, Inc. (NYSE: EVMN) (Evommune or the Company), a clinical-stage biotechnology company developing innovative therapies that target key drivers of chronic inflammatory diseases, today announced...
Business Wire·11d ago
News Placeholder
Evommune (NYSE:EVMN) Trading Down 10.2% - Time to Sell?
Evommune (NYSE:EVMN) Stock Price Down 10.2% - What's Next...
MarketBeat·18d ago
News Placeholder
Evommune (NYSE:EVMN) Trading Down 7.4% - Time to Sell?
Evommune (NYSE:EVMN) Stock Price Down 7.4% - What's Next...
MarketBeat·25d ago
News Placeholder
Evommune, Inc. (NYSE:EVMN) Receives Average Recommendation of "Moderate Buy" from Brokerages
Evommune, Inc. (NYSE:EVMN - Get Free Report) has earned a consensus rating of "Moderate Buy" from the twelve research firms that are presently covering the company, Marketbeat Ratings reports. One...
MarketBeat·1mo ago
News Placeholder
Evommune (NYSE:EVMN) Shares Gap Up - Here's Why
Evommune (NYSE:EVMN) Shares Gap Up - Here's Why...
MarketBeat·1mo ago
<
1
2
...
>

Latest EVMN News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.